Loomis, Sayles & Company’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $116M | Sell |
|
|||||
|
2021
Q1 | $108M | Sell |
|
|||||
|
2020
Q4 | $88.6M | Buy |
|
|||||
|
2020
Q3 | $69.5M | Buy |
|
|||||
|
2020
Q2 | $65.9M | Buy |
|
|||||
|
2020
Q1 | $51.5M | Buy |
|
|||||
|
2019
Q4 | $68.8M | Sell |
|
|||||
|
2019
Q3 | $62.9M | Buy |
|
|||||
|
2019
Q2 | $51.8M | Buy |
|
|||||
|
2019
Q1 | $53.5M | Buy |
|
|||||
|
2018
Q4 | $36.3M | Buy |
|
|||||
|
2018
Q3 | $42.8M | Sell |
|
|||||
|
2018
Q2 | $36.7M | Buy |
|
|||||
|
2018
Q1 | $30.5M | Sell |
|
|||||
|
2017
Q4 | $34.7M | Sell |
|
|||||
|
2017
Q3 | $29.3M | Buy |
|
|||||
|
2017
Q2 | $27.5M | Sell |
|
|||||
|
2017
Q1 | $24.8M | Sell |
|
|||||
|
2016
Q4 | $21.4M | Sell |
|
|||||
|
2016
Q3 | $23.1M | Buy |
|
|||||
|
2016
Q2 | $13M | Buy |
|
|||||
|
2016
Q1 | $8K | Buy |
|
|||||
|
2015
Q4 | $3K | Buy |
|